Handheld Ultrasound Developer Exo Raised $220M In Series C
Executive Summary
As Exo awaits FDA clearance for its handheld ultrasound device, it will use the new funding for planned commercialization. Exo has raised more than $320m to date.
You may also be interested in...
Minute Insight: What Is Going On With Butterfly Network’s Leadership?
Since going public, the company’s share price has flopped, its board has seen a flurry of appointments and resignations over the past year, and now the company is facing investor lawsuits.
Exec Chat: Clarius' Take On The Emerging Handheld Ultrasound Market
In an interview with Medtech Insight, Another newcomer to the handheld ultrasound market weighed in on the competitive environment.
Philips Steps Up Ultrasound Game With Lumify 4.0
The new version of Philips' Lumify gives clinicians access to pulse wave Doppler ultrasound technology, providing real-time blood flow information.